VYPR
Vendor

Peprodev

Products
1
CVEs
1
Across products
1
Status
Private

Products

1

Recent CVEs

1
  • CVE-2024-25933MedMar 17, 2024
    risk 0.34cvss 5.3epss 0.00

    Exposure of Sensitive Information to an Unauthorized Actor vulnerability in Pepro Dev. Group PeproDev Ultimate Invoice.This issue affects PeproDev Ultimate Invoice: from n/a through 1.9.7.